You are here

Press Releases from AlphaMed Press

Comment

Discuss

Embargo Policy: Articles for STEM CELLS and STEM CELLS Translational Medicine are embargoed for release until 9 a.m. Eastern U.S. time on the day the article is posted online. This policy applies to members of the media, authors, institutions' public information officers, and the public. Authors may not discuss their work with the media until 1 week before the mailing date or 1 week before online posting of the article, whichever is earlier, and must ensure that the media representatives agree to abide by the embargo policy. STEM CELLS Translational Medicine may refuse to publish a manuscript, despite acceptance for publication, if it has been prematurely released to the press.

November 3, 2009

Durham, NC, & Craigavon, UK, July 1, 2009 – AlphaMed Press, co-publisher of the journal STEM CELLS®, the first journal in the field of stem cells and regenerative medicine, has promoted Miodrag Stojković to Editor.

Professor Miodrag Stojković is Deputy Director of the Prince Felipe Research Centre and head of its Cellular Reprogramming Laboratory in Valencia, Spain. He led the team that first announced derivation of pluripotent human embryonic stem cells (hESC) from non-viable early human embryos that had stopped their cleavage. First published in STEM CELLS, this technique and stem cells derived with it are now being used to better understand and fight debilitating diseases.

October 5, 2009

stemcellsjrnl_logo_sm

Under Strict Embargo until 00.01 (BST) 8th October 2009

 

Media Contact:
Ben Norman
lifesciencenews@wiley.com

+44(0) 1243 770 375

Stem Cells Which “Fool Immune System” May Provide Vaccination for Cancer

 

August 26, 2009

Donald G. Phinney, PhD, is Professor of Immunology and Microbiology and Associate Director for Research at Tulane's Center for Gene Therapy. Professor Phinney investigates the basic biology of Mesenchymal Stem Cells and their potential use for treatment of chronic lung disease and disorders of the central nervous system. Studies in mice have spurred pre-clinical trials to evaluate the safety and efficacy of intracranial stem cell transplantation for the treatment of neurological sequelae resulting from lysosomal storage diseases.

August 26, 2009

Study Reports Successful Cloning of Human Embryo Using Adult DNA

Key Step Toward Developing Embryonic Stem Cell Lines for Therapeutic Cloning

DURHAM, N.C., January 17 - A California research team has become the first to report, and painstakingly document, the cloning of a human embryo using donated oocytes (egg cells) and DNA from the cells of an adult donor. The study was published online today by the journal "Stem Cells."

August 26, 2009

Key Step toward Clinical Testing of Stem Cells Developed from Patients' Skin Cells

DURHAM, N.C., April 30 - Researchers have succeeded in inducing stem cells grown from mouse skin cells to differentiate into functioning cardiovascular and blood cells, according to a study publishing online tomorrow in the journal "Stem Cells."

August 26, 2009

yia2008_logo

JOURNAL “STEM CELLS” PRESENTS 3rd ANNUAL YOUNG INVESTIGATOR AWARD AT INTERNATIONAL STEM CELL SYMPOSIUM

Pages